Revenue from operations fell 3% y-o-y to ₹44,819 crore in the January to March 2025 quarter against ₹46,269 crore in the year ...

The company reported revenue of ₹369 crore for the quarter, up 24.2% year on year due to healthy demand in its core segments.

EBITDA margin declined to 16.94% in the March 2025 quarter, compared with 21.74% in the corresponding quarter last year ...

Finolex Industries announced its Q4 FY25 results with revenue contracting 5% y-o-y to ₹1,171.8 crore from ₹1,235.4 crore ...

Nibe Limited and Israel bas (OEM) have inked a large international export order worth ₹150.6 Crore to be supplied by Nibe ...

The deal will help boost Sun Pharma’s presence in the high-value specialty drug area in the neurological and critical ...

The new entity is proposed to be named Paras Heven Advanced Drones and will be registered in India with an authorised capital ...

The company's net profit jumped 73.2% YoY to ₹432.2 crore in Q4FY25 against ₹249.6 crore in the year-ago quarter.

This will be achieved by building the 2000 MWac (2600 MW DC) across the Anantapuramu and Sri Sathya Sai districts.

The company's revenue from operations increased 15.8% yoy to ₹1,212.59 crore in Q4 FY25 compared to ₹1,047.08 crore in Q4 ...

Bank of India Mutual Fund - Invest in Bank of India Mutual Fund Mutual Funds and get know about its schemes, returns and NAVs etc. Learn more about Bank of India Mutual Fund Mutual Funds by ...

Zydus Lifesciences has received final approval from the USFDA to launch its isotretinoin capsules USP in six different ...